Stock Comparison

CYTK vs VRTX

Cytokinetics Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.

CYTK

Cytokinetics Inc

Healthcare

VRTX

Vertex Pharmaceuticals Inc

Healthcare

Valuation

Market Cap

$11.16B

$124.70B

P/E (TTM)

—

29.2

Forward P/E

117.7

25.8

Price/Sales

105.5

10.2

Price/Book

60.3

6.4

EV/EBITDA

-15.8

24.0

Dividend Yield

—

Profitability

Net Margin

0.00%

35.50%

Operating Margin

-949.00%

38.10%

Return on Equity

-572.00%

24.20%

Return on Assets

-31.50%

12.10%

Growth (YoY)

Revenue Growth

1126.00%

7.80%

Earnings Growth

0.00%

61.40%

Price & Risk

Beta

0.4

0.3

52-Week High

$84.55

$507.92

52-Week Low

$32.66

$362.50

Analyst Target

$105.60

$548.69

Compare CYTK and VRTX your own way

Try mrmarket.ai free

Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.